Growth of Preterm Infants Fed a Infant Milk Formula Containing High Versus Low Amounts of Beta-palmitate
Recruiting now · Not applicable
Conditions studied: Weight Gain
In brief
The aim of this study is to assess weight gain of preterm infants (gestational age lower than 32 weeks) fed infant milk formula with about 60% beta-palmitate (EX\_IMF) vs infant milk formula with similar macronutrient, mineral and fatty acid composition but lower amounts of beta-palmitate (ST\_IMF). Own mother milk (OMM) fed infants will serve as reference group.
Key facts
- Study ID
- NCT04541095
- Run by
- Ospedali Riuniti Ancona
- People needed
- 150
- Starts
- 2023-01-16
- Expected to finish
- 2027-12-01
- Last updated by the study team
- 2023-01-25
Who can join
Age: 0 and older, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- gestational age between 24 and 32 weeks of gestation at enrollment,
- birth weight greater than 750 grams,
- singleton or twin birth (no triplet or higher),
- fraction of inspired oxygen lower than 0.60 at enrollment,
- feasible enteral feeding,
- cardiovascular stable condition,
- informed consent form signed by at least one parent or legal guardian.
You may not qualify if…
- congenital malformations, genetic, metabolic and endocrine disorders,
- suspicious infection at enrollment,
- intrauterine growth restriction (<10th centile) at enrollment,
- maternal diabetes requiring insulin therapy,
- neonatal asphyxia.
Where it is running
- Ospedali Riuniti di Ancona — Ancona, Italy (enrolling)
- Istituto di Ricerca Città della Speranza — Padua, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.